- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04348591
Identifying the Optimal Neural Target for Misophonia Interventions
Misophonia, the inability to tolerate certain repetitive aversive sounds that are common, is gaining recognition as a debilitating condition. It is not a well-understood condition and there are no known treatments. Up to one in five people report moderate or higher misophonia symptoms; nevertheless, resources aimed at understanding and treating this problem are scarce. In order to align misophonia research with the priorities of large funding agencies such as the National Institute of Mental Health, the investigators propose a novel study aimed at separating misophonic distress from other types of emotional distress. The investigators plan to examine changes in brain activation during presentation and regulation of misophonic versus distressing sounds. Emergent neural networks that may be involved in misophonia will then be tested in the lab with the use of noninvasive neurostimulation, a novel tool that can enhance or inhibit activation in a targeted brain region. The investigators plan to modulate activation in key areas of the misophonia brain circuitry with the aim to identify the optimal neural target for misophonia interventions. Our multidisciplinary team at the Duke Center for Misophonia and Emotion Regulation brings together experts in misophonia, neuroscience, neuromodulation, neurology, and biostatistics who share the long-term goal of developing and refining an intervention for this condition in an environment that is optimal to conduct the proposed research.
The investigators propose to recruit adults who self-report significant misophonia symptoms and adults who meet criteria for a current psychiatric disorder and who self-report difficulties calming down when upset. All participants will undergo a brain imaging session during which misophonic cues; distressing, non-misophonic cues; or neutral cues will be presented. Participants will then be asked to experience, or attempt to downregulate emotions associated with these cues. Based on the imaging results, two personalized neurostimulation targets will be identified: (1) the region in the frontal cortex with the most activity during the downregulation of misophonic versus neutral sounds and (2) the prefrontal region with the strongest functional connectivity to the anterior insular cortex. Participants will receive real or sham neurostimulation over the prefrontal cortex and insula in a random order, while engaging in listening to versus downregulating misophonic, aversive, or neutral cues. The investigators plan to assess emotional dysregulation, psychopathology, and misophonia with a multi-method battery of measures during all three study appointments. Feasibility and acceptability will be examined qualitatively. If successful, our study can be the first step in a series of investigations that establish the unique targets for neural intervention for misophonia.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27710
- Duke University Medical Center-Civitan Bldg
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Interested participants will be excluded if:
- current or past history of mania or psychosis,
- verbal IQ < 70,
- not medically cleared for TMS or fMRI (for example taking medications known to reduce the seizure threshold such as Lamictal, Lithium, Clozaril, stimulants including the ADHD medications (e.g. Ritalin, Adderall), Wellbutrin/Buproprion, Provigil (Modafinil), Aminophylline, and Theophylline, implants, TBI, stroke, etc),
- going to jail in the next 2 months,
- pregnant,
- high risk for suicide
- moderate/severe current alcohol or substance dependence,
- cannot come to Duke for the three study visits.
Inclusion criteria are:
- stable psychotherapy and medication for at least 4 weeks
- self reports high emotional dysregulation OR misophonia
Participants will be matched on gender and age between the two groups
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Misophonia Group
Participants who endorse Misophonia will undergo a neuroimaging session to identify different neurostimulation targets.
Then Misophonic participants will be exposed to aversive and neutral sounds while receiving real or sham neurostimulation over different pre-established neural targets.
|
All participants will learn how to change their thinking in order to be less upset when confronted with stressors
all participants will receive inhibitory, excitatory, and sham transcranial magnetic stimulation over different neural targets during the experimental session.
The purpose of the neurostimulation is not treatment, but causal interference/enhancing of brain circuitry to identify candidate neural regions for future interventions
Other Names:
|
Active Comparator: Emotional Dysregulation Clinical Group
Participants who self report high emotional dysregulation and who meet diagnostic criteria for a DSM disorder will undergo a neuroimaging session to identify different neurostimulation targets.
Then these participants will be exposed to aversive and neutral sounds while receiving real or sham neurostimulation over different pre-established neural targets.
|
All participants will learn how to change their thinking in order to be less upset when confronted with stressors
all participants will receive inhibitory, excitatory, and sham transcranial magnetic stimulation over different neural targets during the experimental session.
The purpose of the neurostimulation is not treatment, but causal interference/enhancing of brain circuitry to identify candidate neural regions for future interventions
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Physiological Outcome: High Frequency Heart Rate Variability (HF-HRV) Recorded During Experimental Blocks
Time Frame: Two minute blocks during the neurostimulation experimental session during which participants listened to or downregulated emotions associated with experimental sounds (45 minutes total).
|
HF-HRV was extracted from 2 minute blocks during which participants engage in a behavioral strategy (listen or downregulate emotions using cognitive restructuring), while listening to neutral, aversive, and misophonic sounds and receive active or sham neurostimulation.
The results represent the average HF-HRV during experimental blocks.
The raw values were transformed using a logarithmic function to preserve the normality assumption.
|
Two minute blocks during the neurostimulation experimental session during which participants listened to or downregulated emotions associated with experimental sounds (45 minutes total).
|
Skin Conductance Level (SCL)
Time Frame: Two minute blocks during the neurostimulation experimental session (when participants listened to or downregulated emotions associated with experimental sounds)
|
Physiological arousal measured by SCL during each experimental block was extracted using Acqknowledge software and BIOPAC hardware (during the neurostimulation session).
Raw galvanic skin response was continuously collected throughout the experiment.
Raw data was then examined for abrupt changes (skin conductance responses), which were removed.
The processed data was then averaged for each two minute experimental block.
Higher SCL means higher arousal.
|
Two minute blocks during the neurostimulation experimental session (when participants listened to or downregulated emotions associated with experimental sounds)
|
Behavioral Outcome: Acceptability of Procedures
Time Frame: At the end of the neurostimulation session (session 3 in the experiment), which occured within a month of the initial assessment
|
The investigators will record how many participants completed the neurostimulation session as a marker of acceptability.
|
At the end of the neurostimulation session (session 3 in the experiment), which occured within a month of the initial assessment
|
Neuroimaging Outcome: Differential Change in BOLD Signal Between Groups Within the Dorsolateral Prefrontal Cortex (dlPFC), That is Greater During Regulation of Misophonic Versus Non-misophonic Distress
Time Frame: during the neuroimaging session, within a month of the intake assessment
|
Blood Oxygenation Level Dependent (BOLD) imaging is a technique that is commonly used for estimating brain activity using functional magnetic resonance imaging (fMRI).
Change in the fMRI BOLD signal notes changes in brain blood flow and blood oxygenation, which are associated with neuronal activity.
Higher values indicate higher activity changes within a contrast of interes.
A dlPFC mask was employed to find the maximum value of the [downregulate misophonic sounds > downregulate aversive sounds] contrast in this region.
Once the voxel containing this maximum was identified, a 6 mm sphere ROI was created around this spot (restricted to the dlPFC mask) and the average contrast value within this sphere was used as the outcome variable.
|
during the neuroimaging session, within a month of the intake assessment
|
Neuroimaging Outcome: Differential Change in BOLD Signal Within the Ventromedial Prefrontal Cortex (vmPFC) When Engaging in the Regulation of Emotional Versus Misophonic Distress
Time Frame: during the neuroimaging session, within a month of the intake assessment
|
Blood Oxygenation Level Dependent (BOLD) imaging is a technique that is commonly used for estimating brain activity using functional magnetic resonance imaging (fMRI).
Change in the fMRI BOLD signal notes changes in brain blood flow and blood oxygenation, which are associated with neuronal activity.
A vmPFC mask was employed to find the maximum value of the [downregulate misophonic sounds > downregulate aversive sounds] contrast in this region.
Once the voxel containing this maximum was identified, a 6 mm sphere ROI was created around this spot (restricted to the vmPFC mask) and the average contrast value within this sphere will be used as the outcome variable.
Higher scores indicate more activity when downregulating misophonic versus aversive sounds.
|
during the neuroimaging session, within a month of the intake assessment
|
Neuroimaging Outcome: Differential Change in BOLD Signal Within the Anterior Insular Cortex (AIC) Activation When Being Presented With Cues for Emotional Versus Misophonic Distress
Time Frame: during the neuroimaging session, within a month of the intake assessment
|
Blood Oxygenation Level Dependent (BOLD) imaging is a technique that is commonly used for estimating brain activity using functional magnetic resonance imaging (fMRI).
Change in the fMRI BOLD signal notes changes in brain blood flow and blood oxygenation, which are associated with neuronal activity.
An AIC mask was employed to find the maximum value of the [hear misophonic sounds > hear aversive sounds] contrast in this region.
Once the voxel containing this maximum was identified, a 6 mm sphere ROI was created around this spot (restricted to the AIC mask) and the average contrast value within this sphere will be used as the outcome variable.
A larger score indicates more activity when hearing misophonic versus aversive sounds.
|
during the neuroimaging session, within a month of the intake assessment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Subjective Units of Distress (SUDS)
Time Frame: Baseline, during the experimental blocks during the neurostimulation session (which will occur within a month of the initial assessment)
|
Self reported distress after experimental blocks will also be examined for differences when accounting for baseline distress (during the neurostimulation session).
SUDS will be measured using a 0-9 sale, where 0 indicates no distress, and 9 indicates extreme distress.
The outcome measure represents SUDS after negative sound presentations (misophonic and aversive) minus SUDS after baseline.
Higher SUDS represents higher distress.
|
Baseline, during the experimental blocks during the neurostimulation session (which will occur within a month of the initial assessment)
|
Emotional Dysregulation as Measured by the Difficulties in Emotion Regulation Scale (DERS)
Time Frame: From baseline to the end of neurostimulation session, an average of 4 weeks.
|
A self report assessing difficulties regulating emotions will be examined before and after the experiment (i.e., at the end of the neurostimulation session).
The DERS ranges from 36 to 180, with higher scores indicating more dysregulation.
|
From baseline to the end of neurostimulation session, an average of 4 weeks.
|
Self-reported Health Status as Measured by the Patient Reported Outcome Measurement Information System (PROMIS)-43 Adult Profile
Time Frame: At baseline
|
The PROMIS-43 is a 43-item questionnaire assessing health status in seven domains: physical function, anxiety, depression, fatigue, sleep disturbance, pain interference, and participation in social roles.
Lower scores indicate less impairment in functioning when compared to higher scores.
Each item has five response options ranging in value from 1 to 5, except for the 1 Pain Intensity item which has eleven response options ranging in value from 0 to 10.
A raw score is created from each domain that makes up the Profile.
Each domain raw score ranging from 6-30 corresponds to a T-Score in the PROMIS scoring manual.
|
At baseline
|
Number of Clusters Across the Whole Brain With Significant BOLD Changes Between Groups When Contrasting the Exposure to Aversive Versus Neutral Sounds.
Time Frame: During the neuroimaging session, within a month of the intake assessment
|
Blood Oxygenation Level Dependent (BOLD) imaging is a technique that is commonly used for estimating brain activity using functional magnetic resonance imaging (fMRI).
Change in the fMRI BOLD signal notes changes in brain blood flow and blood oxygenation, which are associated with neuronal activity.
The BOLD signal contrast between engaging with aversive sounds and engaging with neutral sounds were compared between groups across the whole brain on a voxel-wise basis.
Voxel-wise significant results (i.e., z > 2.3) were clustered to statistically correct for multiple comparisons.
The number of significant clusters that emerged from this analysis in each group are presented as outcome.
|
During the neuroimaging session, within a month of the intake assessment
|
Number of Clusters Across the Whole Brain With Significant BOLD Changes Between Groups When Contrasting the Exposure to Misophonic Versus Aversive Sounds.
Time Frame: during the neuroimaging session, within a month of the intake assessment
|
Blood Oxygenation Level Dependent (BOLD) imaging is a technique that is commonly used for measuring brain activity using functional magnetic resonance imaging (fMRI).
Change in a BOLD signal detected in fMRI, notes changes in brain blood flow and blood oxygenation.
Neural activation across the brain when engaging with misophonic sounds versus aversive sounds during the neuroimaging day.
The BOLD signal contrast between engaging with misophonic sounds and engaging with aversive sounds were compared between groups across the whole brain on a voxel-wise basis.
Voxel-wise significant results (i.e., z > 2.3) were clustered to statistically correct for multiple comparisons.
The number of significant clusters that emerged from this analysis in each group are presented as outcome.
|
during the neuroimaging session, within a month of the intake assessment
|
Number of Clusters Across the Whole Brain With Significant BOLD Changes Between Groups When Contrasting the Downregulation of Distress Associated With Misophonic Sounds to Exposure to Misophonic Sounds
Time Frame: during the neuroimaging session, within a month of the intake assessment
|
Blood Oxygenation Level Dependent (BOLD) imaging is a technique that is commonly used for estimating brain activity using functional magnetic resonance imaging (fMRI).
Change in the fMRI BOLD signal notes changes in brain blood flow and blood oxygenation, which are associated with neuronal activity.
The BOLD signal contrast between regulating versus engaging with misophonic sounds across the entire brain was compared between participant groups on a voxel-wise basis.
Voxel-wise results were clustered to statistically correct for multiple comparisons.
The number of significant clusters within each group are presented as outcome (more cluster indicates more differences during regulation in that group versus the control group).
|
during the neuroimaging session, within a month of the intake assessment
|
Number of Clusters Across the Whole Brain With Significant BOLD Changes Between Groups When Contrasting the Downregulation of Distress Associated With Aversive Sounds to Exposure to AversiveSounds
Time Frame: during the neuroimaging session, within a month of the intake assessment
|
Blood Oxygenation Level Dependent (BOLD) imaging is a technique that is commonly used for estimating brain activity using functional magnetic resonance imaging (fMRI).
Change in the fMRI BOLD signal notes changes in brain blood flow and blood oxygenation, which are associated with neuronal activity.
The BOLD signal contrast between regulating and engaging with aversive sounds was compared between participant groups on a voxel-wise basis.
Voxel-wise results were clustered to statistically correct for multiple comparisons.
The number of significant clusters within each group are reported as the outcome measure.
|
during the neuroimaging session, within a month of the intake assessment
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Andrada D Neacsiu, PhD, Duke Health
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- Pro00103863
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Participant data from the study was shared to the Duke Research Data Repository (RDR).
Neacsiu, A., LaBar, K., Rosenthal, M. Z., Bukhari-Parlakturk, N., Kelley, L. (2022). Identifying the optimal neural target for misophonia interventions. Duke Research Data Repository. https://doi.org/10.7924/r4ww7jg4k
IPD Sharing Time Frame
IPD Sharing Access Criteria
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Misophonia
-
University of Warsaw, PolandDuke UniversityRecruiting
-
Icahn School of Medicine at Mount SinaiRecruitingMisophoniaUnited States
-
Hacettepe UniversityCompleted
-
Duke UniversityCompletedMisophoniaUnited States
-
University of South FloridaUniversity of MiamiUnknownMisophoniaUnited States
-
Duke UniversityMisophonia Research FundNot yet recruitingSensory Processing Disorder | Anxiety Disorder | Misophonia | Emotion Dysregulation | Auditory Over Responsivity | Sound SensitivityUnited States
Clinical Trials on Cognitive Restructuring
-
Berlin Center for the Treatment of Torture VictimsCompletedPosttraumatic Stress Disorder (PTSD)Germany
-
Michelle Choong Poh KinNot yet recruitingPosttraumatic Growth | Breakup Distress
-
Christoph-Dornier-Stiftung für Klinische PsychologieWestfälische Wilhelms-Universität MünsterCompletedObsessive-Compulsive DisorderGermany
-
Duke UniversityBrain & Behavior Research FoundationCompletedPersonality Disorders | Depression | Anxiety | Eating Disorders | Somatic Disorders | Trauma and Stress-related Disorders | Obsessive Compulsive Disorders | Difficulties With Cognitive Emotion RegulationUnited States
-
Mental Health Services in the Capital Region, DenmarkUniversity of CopenhagenCompletedPosttraumatic Stress DisorderDenmark
-
University of BernUniversity of LuebeckActive, not recruitingSocial Anxiety Disorder (Social Phobia)Switzerland
-
University of ChicagoCompletedAnger | Intermittent Explosive DisorderUnited States
-
University of AmsterdamNetherlands Organisation for Scientific ResearchNot yet recruiting
-
National Institute of CancerologíaEnrolling by invitationCervical Cancer | Psychological Distress | Coping SkillsMexico
-
Brigham and Women's HospitalCompletedProstate CancerUnited States